Master’s Thesis: Pharmacologic profiling of novel compounds via fluorometric analyses of monoamine transporter responses
(Thesis release date: July 18, 2024)

I utilized a unique fluorescent analysis technique to explore three therapeutic compounds of interest (in-vitro) which contain structural similarity to fluoxetine (a selective serotonin reuptake inhibitor).

These assays allowed me to measure selectivity of these novel compounds at the monoamine transporters (SERT, DAT, and NET) and ultimately classify each based off of their selectivity profiles.

I then developed OPOMed, a theoretical personalized medicine approach for users to upload brain PET scans for determination of the best psychopharmacologic treatment option.